Skip to content

High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria

High Dose Vitamin D Supplementation in Treatment of Chronic Spontaneous Urticaria

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02873364
Enrollment
80
Registered
2016-08-19
Start date
2016-08-31
Completion date
2017-01-31
Last updated
2016-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urticaria

Brief summary

Chronic spontaneous urticaria is an inflammatory disease which is characterized with intermittent or daily urticaria. This diseases lasts for more than 6 weeks. Several recent studies have suggested a role for vitamin D in modulation of immune system and pathogenesis of chronic urticaria.

Interventions

DRUGVitamin D3 (High dose)

Daily 4000 unites vitamin D

DRUGVitamin D3 (Low dose)

Daily 600 unites vitamin D

Sponsors

Shiraz University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Uriticaria or angioedema daily or more than 3 days a weeks for at least 6 weeks

Exclusion criteria

* Physical urticaria aquired or hereditary angioedema Calcium level \> 10.3 mg/dl Glomerular filtration rate \<50 Sarcoidosis Primary hyperparathyroidism Granulomatous diseases Malignancies Pregnancy Lactation

Design outcomes

Primary

MeasureTime frameDescription
Urticaria symptom severity questionnaire after 1 week1 weeksUrticaria Symptom Severity ranging from 0 to 93

Secondary

MeasureTime frameDescription
Urticaria symptom severity questionnaire after 6 week6 weeksUrticaria Symptom Severity ranging from 0 to 93
Urticaria symptom severity questionnaire after 12 week12 weeksUrticaria Symptom Severity ranging from 0 to 93

Countries

Iran

Contacts

Primary ContactKeramatallah Jahanshahi, MD
kjahanshahi91@gmail.com+989177416523

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026